Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Pulse Biosciences, Inc (PLSE) had Normalized Pre-Tax Income of $-19.17M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-19.17M |
|
-- |
|
-- |
|
$20.27M |
|
$-20.27M |
|
$1.11M |
|
$-19.17M |
|
|
Normalized Pre-Tax Income |
$-19.17M |
$-19.17M |
|
$-19.17M |
|
$-19.17M |
|
$-19.17M |
|
$-20.27M |
|
$-20.00M |
|
67.28M |
|
67.28M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$108.16M |
|
$1.11M |
|
$12.09M |
|
$120.25M |
|
$8.98M |
|
-- |
|
$6.79M |
|
$15.76M |
|
$104.49M |
|
$100.79M |
|
$104.49M |
|
67.28M |
|
| Cash Flow Statement Financials | |
$-26.33M |
|
$-0.17M |
|
$14.81M |
|
$118.04M |
|
$106.35M |
|
$-11.69M |
|
$10.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.34% |
|
-19.02% |
|
-15.94% |
|
-18.34% |
|
$1.55 |
|
$-0.39 |
|
$-0.39 |
|